IRCT201204099429N1CompletedPhase 3
Therapeutic effect of Fluticasone and Montelukast in children younger than 5 years with recurrent wheeze
Tabriz University of Medical Sciences, Assistance Research0 sites68 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 68
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to 5 years (—)
- Sex
- All
Inclusion Criteria
- •(no abnormalities underlying anatomic disease? family history of allergies and asthma patient ) And exclusion criteria: (anatomical issues such as the children with Gastroesophageal Reflux Disease? Cystic fibrosis ? underlying medical condition such as cardiovascular problems they are not in the study).
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Montelukast and Fluticasone effect in wheezeasthma.J45.0IRCT201309079429N3Tabriz University of Medical Sciences68
Completed
Not Applicable
The effect of combination therapy of fluticasone furoate nasal spray with levocetirizine hydrochloride in patients with Japanese cedar pollinosis in an artificial exposure chamber(OHIO Chamber).Japanese cedar pollinosisJPRN-UMIN000006502ippon Medical School42
Completed
Not Applicable
Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in JapaCOPDJPRN-UMIN000007544Kyusyu Asthma & COPD Forum1,008
Completed
Not Applicable
Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in JapaCOPDJPRN-UMIN000003403Kyusyu Asthma & COPD Forum1,008
Completed
Not Applicable
Comparative efficacy of fluticasone furoate/umeclidinium/vilanterol(FF/UMEC/VI)versus budesonide/glycopyrrolate/formoterol fumarate(B/G/F) therapies in COPD patientsCOPDJPRN-UMIN000041089ippon Koukan Hospital50